Lung Involvement in Children with Hereditary Autoinflammatory Disorders

Short-lived systemic inflammatory reactions arising from disrupted rules in the innate immune system are the operating platforms of hereditary autoinflammatory disorders (HAIDs). Multiple organs may be involved and aseptic inflammation leading to disease-specific phenotypes defines most HAIDs. Lungs are infrequently involved in children with HAIDs: the most common pulmonary manifestation is pleuritis in familial Mediterranean fever (FMF) and tumor necrosis factor receptor-associated periodic syndrome (TRAPS), respectively caused by mutations in the MEFV and TNFRSF1A genes, while interstitial lung disease can be observed in STING-associated vasculopathy with onset in infancy (SAVI), caused by mutations in the TMEM173 gene. The specific pleuropulmonary diseases may range from sub-clinical abnormalities during inflammatory flares of FMF and TRAPS to a severe life-threatening disorder in children with SAVI.

[1]  R. Gershoni-baruch,et al.  Pulmonary manifestations and function tests in children genetically diagnosed with FMF , 2003, Pediatric pulmonology.

[2]  S. Sawhney,et al.  Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders , 2001, Archives of disease in childhood.

[3]  T. Molina,et al.  Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. , 2014, The Journal of clinical investigation.

[4]  M. Audran,et al.  Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): definition, semiology, prognosis, pathogenesis, treatment, and place relative to other periodic joint diseases. , 2004, Joint, bone, spine : revue du rhumatisme.

[5]  D. Rigante,et al.  The multi-face expression of familial Mediterranean fever in the child. , 2006, European review for medical and pharmacological sciences.

[6]  M. Shohat,et al.  Possible protection against asthma in heterozygotes for familial Mediterranean fever. , 1994, American journal of medical genetics.

[7]  M. Galeazzi,et al.  Autoinflammatory diseases and cardiovascular manifestations , 2011, Annals of medicine.

[8]  D. Kastner,et al.  Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations. , 2000, Archives of dermatology.

[9]  D. Rigante.  Autoinflammatory syndromes behind the scenes of recurrent fevers in children. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[10]  A. Ramanan,et al.  Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy. , 2016, American journal of respiratory and critical care medicine.

[11]  C. Şahan,et al.  PULMONARY AMYLOIDOSIS IN FAMILIAL MEDITERRANEAN FEVER , 2006, Acta clinica Belgica.

[12]  R. Cimaz,et al.  The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy , 2014, Clinical Rheumatology.

[13]  C. Rosé,et al.  Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. , 2007, Arthritis and rheumatism.

[14]  M. Sormani,et al.  Long-Term Clinical Profile of Children With the Low-Penetrance R92Q Mutation of the TNFRSF1A Gene , 2011, Arthritis and rheumatism.

[15]  M. Pras,et al.  Thoracic and lung involvement in familial Mediterranean fever (FMF). , 2002, Clinics in chest medicine.

[16]  H. Telatar,et al.  Absence of asthma in patients with familial Mediterranean fever. , 1994, Israel journal of medical sciences.

[17]  L. Punzi,et al.  Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders , 2013, Mediators of inflammation.

[18]  F. Rieux-Laucat,et al.  Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Mimic of Childhood Granulomatosis With Polyangiitis. , 2015, JAMA dermatology.

[19]  A. Vitale,et al.  The hereditary autoinflammatory disorders uncovered. , 2014, Autoimmunity reviews.

[20]  J. Casanova,et al.  STING-associated vasculopathy with onset in infancy--a new interferonopathy. , 2014, The New England journal of medicine.

[21]  M. Galeazzi,et al.  Untangling the Web of Systemic Autoinflammatory Diseases , 2014, Mediators of inflammation.

[22]  K. Ishii,et al.  Pulmonary Necrotizing Granulomas in a patient with familial mediterranean fever , 2015, Modern rheumatology.

[23]  D. Rigante,et al.  The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. , 2010, European review for medical and pharmacological sciences.

[24]  K. Psathakis,et al.  Unilateral lymphocytic pleuritis as a manifestation of familial Mediterranean fever. , 2008, Chest.

[25]  M. Pras,et al.  Pulmonary associations in familial Mediterranean fever. , 1999, Current opinion in pulmonary medicine.

[26]  D. Levy,et al.  Constitutive type I interferon modulates homeostatic balance through tonic signaling. , 2012, Immunity.

[27]  S. Özen,et al.  Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus , 2016, Rheumatology International.

[28]  Ha Won Kim,et al.  Activated STING in a vascular and pulmonary syndrome. , 2014, The New England journal of medicine.

[29]  S. Shibolet,et al.  Serosal exudates in familial Mediterranean fever. , 1967, American journal of clinical pathology.

[30]  Donato Rigante,et al.  The fresco of autoinflammatory diseases from the pediatric perspective. , 2012, Autoimmunity reviews.

[31]  D. Rigante,et al.  The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. , 2006, European review for medical and pharmacological sciences.

[32]  H. Colebatch,et al.  Familial Mediterranean fever with involvement of the lungs. , 1971, Australian and New Zealand journal of medicine.

[33]  T. Morishima,et al.  Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[34]  S. Esposito,et al.  Debate around infection-dependent hemophagocytic syndrome in paediatrics , 2013, BMC Infectious Diseases.

[35]  L. Punzi,et al.  Working the endless puzzle of hereditary autoinflammatory disorders , 2014, Modern rheumatology.

[36]  L. Punzi,et al.  Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. , 2014, Autoimmunity reviews.

[37]  B. Rudolph,et al.  “Periodic fever” without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis , 2005, Annals of the Rheumatic Diseases.

[38]  S. Özen,et al.  Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy. , 2016, Journal of the American Academy of Dermatology.

[39]  E. Silvestri,et al.  Macrophage activation syndrome in the course of monogenic autoinflammatory disorders , 2015, Clinical Rheumatology.

[40]  T. Horiuchi,et al.  Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature , 2013, Modern rheumatology.

[41]  Eric O Long,et al.  Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. , 2012, The New England journal of medicine.

[42]  M. Shlezinger,et al.  Decreased incidence of asthma in patients with familial Mediterranean fever. , 1990, Israel journal of medical sciences.

[43]  E. Silvestri,et al.  Key facts and hot spots on tumor necrosis factor receptor‐associated periodic syndrome , 2014, Clinical Rheumatology.

[44]  L. Punzi,et al.  Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues , 2013, International journal of rheumatology.

[45]  M. Galeazzi,et al.  From the Mediterranean to the Sea of Japan: The Transcontinental Odyssey of Autoinflammatory Diseases , 2013, BioMed research international.

[46]  Ivan K. Chinn,et al.  Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease , 2016, Journal of Clinical Immunology.

[47]  I. Touitou,et al.  The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry , 2013, Annals of the rheumatic diseases.

[48]  M. Galeazzi,et al.  Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives , 2015, Mediators of inflammation.

[49]  F. Rieux-Laucat,et al.  Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation). , 2016, Chest.